Search Within

Wolfgang Andreas Weber

Formats
  1. Journal Article (114)
  2. Meeting Abstract (55)
  3. Book Section (2)
  4. Conference Paper (2)
Groups
  1. Molecular Imaging and Therapy Service (173)
  2. Radiology, Department of (173)
  3. Sloan Kettering Institute Postdocs (88)
  4. GSK Faculty (66)
  5. Radiochemistry and Imaging Sciences Service (61)
  6. Medical Physics (47)

More Groups

People
  1. Jason Lewis (30)
  2. Neeta Pandit-Taskar (23)
  3. Serge Lyashchenko (23)
  4. Thomas Reiner (23)
  5. Joseph O'Donoghue (21)
  6. Hanwen Zhang (18)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2020 (5)
  5. 2019 (16)
  6. 2018 (23)

More Years

Publications
  1. Journal of Nuclear Medicine (65)
  2. European Journal of Nuclear Medicine and Molecular Imaging (20)
  3. Molecular Imaging and Biology (6)
  4. Journal of Clinical Oncology (5)
  5. Strahlentherapie und Onkologie (5)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. Society of Nuclear Medicine (65)
  2. Springer (34)
  3. Elsevier Inc. (10)
  4. American Association for Cancer Research (9)
  5. Springer Verlag (6)
  6. American Society of Clinical Oncology (5)

More Publishers

Results (173)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • (89)Zr-immuno-PET: Toward a noninvasive clinical tool to measure target engagement of therapeutic antibodies in vivo
    Journal Article

    Jauw, Y. W. S.; O'Donoghue, J. A.; Zijlstra, J. M.; Hoekstra, O. S.; Willemien Menke-van der Houven van Oordt, C.; Morschhauser, F.; Carrasquillo, J. A.; Zweegman, S.; Pandit-Taskar, N.; Lammertsma, A. A.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Retooling a blood-based biomarker: Phase I assessment of the high-affinity CA19-9 antibody HuMAB-5B1 for immuno-PET imaging of pancreatic cancer
    Journal Article

    Lohrmann, C.; O'Reilly, E. M.; O'Donoghue, J. A.; Pandit-Taskar, N.; Carrasquillo, J. A.; Lyashchenko, S. K.; Ruan, S.; Teng, R.; Scholz, W.; Maffuid, P. W.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Histologically-confirmed diagnostic efficacy of (18)F-rhPSMA-7 positron emission tomography for N-staging of patients with high risk primary prostate cancer
    Meeting Abstract

    Kroenke, M.; Wurzer, A.; Schwamborn, K.; Ulbrich, L.; Jooay, L.; Maurer, T.; Horn, T.; Kropf, S.; Haller, B.; Wester, H.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • PSMA-ligand PET/CT in patients with biochemical recurrent prostate cancer after radical prostatectomy: Matched-pair comparison of (68)Ga-PSMA-11 and (18)F-PSMA-1007
    Meeting Abstract

    Kroenke, M.; Rauscher, I.; Horn, T.; Weber, W.; Eiber, M.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Multispectral optoacoustic tomography: A novel label-free imaging technique for the assessment of hyperthyroid diseases
    Meeting Abstract

    Kroenke, M.; Karlas, A.; Fasoula, N.; Markwardt, N.; Scheidhauer, K.; Eiber, M.; Weber, W.; Ntziachristos, V.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • F-18 FDG PET/CT for monitoring immunotherapy with PD-1 blockade in patients with advanced melanoma
    Meeting Abstract

    Ito, K.; Nakajima, R.; Michaud, L.; Weber, W.; Schoder, H.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Prognostic value of metabolic parameters on pretreatment F-18 FDG PET/CT in patients with advanced melanoma treated with pembrolizumab
    Meeting Abstract

    Ito, K.; Michaud, L.; Nakajima, R.; Weber, W.; Schoder, H.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • (89)Zr-immuno-PET: Towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo
    Meeting Abstract

    Jauw, Y.; O'Donoghue, J.; Zijlstra, J.; Hoekstra, O.; Menke-van der Houven van Oordt, C.; Morschhauser, F.; Carrasquillo, J.; Zweegman, S.; Pandit-Taskar, N.; Lammertsma, A.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • 18F-rhPSMA-7 positron emission tomography (PET) for the detection of biochemical recurrence of prostate cancer following radical prostatectomy
    Meeting Abstract

    Eiber, M.; Kroenke, M.; Wurzer, A.; Ulbrich, L.; Jooay, L.; Maurer, T.; Kropf, S.; Horn, T.; Wester, H.; Weber, W.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Prospective study of the radiolabeled GRPR antagonist BAY86-7548 for positron emission tomography/computed tomography imaging of newly diagnosed prostate cancer
    Journal Article

    Touijer, K. A.; Michaud, L.; Alvarez, H. A. V.; Gopalan, A.; Kossatz, S.; Gonen, M.; Beattie, B.; Sandler, I.; Lyaschenko, S.; Eastham, J. A.; more...
    European Urology Oncology (2019)

    Fulltext@MSK | Save